Best-Worst Scaling of Patient Preferences for Public Funding for HIV: Spend Less on Medication and More on Economic Support

BACKGROUND: In 2023, Washington State mandated that all antiretroviral drugs (ARVs) be made available to Medicaid-insured people with HIV (PWH) without prior authorizations, a change estimated to increase ARV spending by ∼20%. How this policy aligns with patient priorities is unknown. SETTING: Seattle, Washington, USA. METHODS: We administered a best-worst scaling survey to 148 Medicaid-insured PWH to assess 9 options for allocating new HIV-related spending: 1) unrestricted access to all ARVs (unrestricted utilization) or restricted utilization of some ARVs plus each of the following 2) $200/month cash, 3) $200/month rental/utility assistance, 4) $200/month food assistance, 5) better dental care access, 6) better substance abuse treatment access, 7) better mental health care access, 8) better access to walk-in HIV care, or 9) additional case management. Participants separately rated choices as most and least helpful for themselves and for all PWH. We used conditional logistic regression to calculate preferences for each option. RESULTS: Most participants were White (55%), male (80%), and had incomes <$1000/month (69%). When selecting options for themselves, participants' 3 most preferred choices were restricted ARV utilization plus $200/month for cash, rent/utility assistance, or food; model findings suggest that 47% participants considered one of these options as their most preferred choice vs. 8% prioritizing unrestricted ARV utilization. Preferences for self and community were mostly aligned. CONCLUSION: This patient population prioritized economic support over accessing more costly ARVs or other services. Current HIV-related public spending prioritizing expensive ARVs over patients' socioeconomic needs may not be aligned with patient preferences.

Authors

Institutions

Publication Details

Journal
JAIDS Journal of Acquired Immune Deficiency Syndromes
Published
2026-11-18
DOI
https://doi.org/10.1097/qai.0000000000004002
Primary Topic
HIV/AIDS Research and Interventions
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Best-Worst Scaling of Patient Preferences for Public Funding for HIV: Spend Less on Medication and More on Economic Support

Shireesha Dhanireddy, Monisha Sharma, Matthew Robert Golden, Julie Dombrowski et al.
1 links
JAIDS Journal of Acquired Immune Deficiency Syndromes
HIV/AIDS Research and Interventions
article

Best-Worst Scaling of Patient Preferences for Public Funding for HIV: Spend Less on Medication and More on Economic Support

Shireesha Dhanireddy, Monisha Sharma, Matthew Robert Golden, Julie Dombrowski, Katherine Holzhauer, Shiven Bhardwaj, Jehan Budak
article en

Abstract

BACKGROUND: In 2023, Washington State mandated that all antiretroviral drugs (ARVs) be made available to Medicaid-insured people with HIV (PWH) without prior authorizations, a change estimated to increase ARV spending by ∼20%. How this policy aligns with patient priorities is unknown. SETTING: Seattle, Washington, USA. METHODS: We administered a best-worst scaling survey to 148 Medicaid-insured PWH to assess 9 options for allocating new HIV-related spending: 1) unrestricted access to all ARVs (unrestricted utilization) or restricted utilization of some ARVs plus each of the following 2) $200/month cash, 3) $200/month rental/utility assistance, 4) $200/month food assistance, 5) better dental care access, 6) better substance abuse treatment access, 7) better mental health care access, 8) better access to walk-in HIV care, or 9) additional case management. Participants separately rated choices as most and least helpful for themselves and for all PWH. We used conditional logistic regression to calculate preferences for each option. RESULTS: Most participants were White (55%), male (80%), and had incomes <$1000/month (69%). When selecting options for themselves, participants' 3 most preferred choices were restricted ARV utilization plus $200/month for cash, rent/utility assistance, or food; model findings suggest that 47% participants considered one of these options as their most preferred choice vs. 8% prioritizing unrestricted ARV utilization. Preferences for self and community were mostly aligned. CONCLUSION: This patient population prioritized economic support over accessing more costly ARVs or other services. Current HIV-related public spending prioritizing expensive ARVs over patients' socioeconomic needs may not be aligned with patient preferences.

JAIDS Journal of Acquired Immune Deficiency Syndromes
Public Health – Seattle & King County (US), University of Washington (US)
Good health and well-being, Reduced inequalities
HIV/AIDS Research and Interventions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon